66450-1-Ig

antibody from Proteintech Group

Targeting: TNFSF9 4-1BB-L, 4-1BBL

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

66450-1-Ig

Provider

Proteintech Group

Product name

TNFSF9 antibody

Antibody type

Monoclonal

Description

TNFSF9 antibody (Cat. #66450-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.

Reactivity

Human

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

1B4B1

Vial size

20ul, 150ul

References

Submitted references

Leucine aminopeptidase LyLAP enables lysosomal degradation of membrane proteins.

Jain A, Heremans I, Rademaker G, Detomasi TC, Rohweder P, Anderson D, Zhang J, Hernandez GA, Gupta S, von Linde T, Lange M, Spacci M, Luo J, Citron YR, Olzmann JA, Dawson DW, Craik CS, Bommer G, Perera RM, Zoncu R
Science (New York, N.Y.) 2025 Mar 28;387(6741):eadq8331

---

Integrative analysis of bulk and single-cell sequencing reveals TNFSF9 as a potential regulator in microsatellite instability stomach adenocarcinoma.

Zhou J, Zhang Y, Liu Y, Li J, Zhang W, Wang J, Yao X, Feng H, Zheng J, Li Y
European journal of medical research 2025 Mar 28;30(1):214

---

HBV infection effects prognosis and activates the immune response in intrahepatic cholangiocarcinoma.

Li Z, Gao Q, Wu Y, Ma X, Wu F, Luan S, Chen S, Shao S, Shen Y, Zhang D, Feng F, Yuan L, Wei S
Hepatology communications 2024 Jan 1;8(1)

---

Leucine Aminopeptidase LyLAP enables lysosomal degradation of membrane proteins.

Jain A, Heremans I, Rademaker G, Detomasi TC, Hernandez GA, Zhang J, Gupta S, von Linde T, Lange M, Spacci M, Rohweder P, Anderson D, Citron YR, Olzmann JA, Dawson DW, Craik CS, Bommer G, Perera RM, Zoncu R
bioRxiv : the preprint server for biology 2024 Dec 14;

---

Clinical significance of nonerythrocytic spectrin Beta 1 (SPTBN1) in human kidney renal clear cell carcinoma and uveal melanoma: a study based on Pan-Cancer Analysis.

Tang W, Shao Q, He Z, Zhang X, Li X, Wu R
BMC cancer 2023 Apr 3;23(1):303

---

TNFSF9 promotes metastasis of pancreatic cancer by regulating M2 polarization of macrophages through Src/FAK/p-Akt/IL-1β signaling.

Wu J, Wang Y, Yang Y, Liu F, Jiang Z, Jiang Z
International immunopharmacology 2022 Jan;102:108429

---

TNFSF9 promotes metastasis of pancreatic cancer through Wnt/Snail signaling and M2 polarization of macrophages.

Wu J, Wang Y, Yang Y, Liu F, Chen J, Jiang Z, Jiang Z
Aging 2021 Sep 13;13(17):21571-21586